U.S. markets ended mixed Friday, with the Dow and S&P 500 slipping while the Nasdaq managed a modest gain. Investors took profits and weighed a wave of earnings reports, leading to a more cautious tone. Nvidia dipped on reports of weaker AI chip demand in Asia, while Adobe slid after issuing cautious guidance—though broader tech strength helped lift the Nasdaq into positive territory. The S&P 500 declined as industrial and consumer discretionary names like Caterpillar and Nike fell on concerns around global demand and soft U.S. sales. The Dow lost ground, pressured by UnitedHealth amid updates on a CMS audit probe and Goldman Sachs following disappointing trading revenue. Energy stocks like Chevron and Halliburton edged lower despite a modest uptick in oil prices, reflecting margin concerns. Overall, the session reflected selective positioning as investors await next week’s Fed commentary and key earnings. Market Drivers: 📱Technology: Nvidia Slips, Adobe Drops: Nvidia (NVDA) fell amid reports of slowing AI chip demand from Asian cloud providers, raising concerns about near-term enterprise orders. Adobe (ADBE) declined after issuing cautious forward guidance tied to softness in digital media subscriptions and enterprise IT spending. 🏦 Financials: Goldman Sachs Falls, Morgan Stanley Steady: Goldman Sachs (GS) dropped following a weaker-than-expected Q2 trading revenue update and tepid investment banking activity. Morgan Stanley (MS) held flat as strong wealth management growth helped offset softness in its capital markets segment. 🚗 Automotive: Tesla Edges Lower, Rivian Rises: Tesla (TSLA) dipped slightly after announcing delays in its Cybertruck ramp-up timeline, sparking renewed production concerns. Rivian (RIVN) climbed on upbeat delivery figures and a newly announced fleet partnership with a major logistics provider. 🏥 Healthcare: UnitedHealth Drops, Eli Lilly Climbs: UnitedHealth Group (UNH) sank following updates on a CMS audit probe tied to Medicare Advantage payments. Eli Lilly (LLY) gained after releasing positive mid-stage trial data for its obesity drug candidate, boosting sentiment on its expanding pipeline. 🍔 Consumer Discretionary: Nike Falls, Target Gains: Nike (NKE) declined on soft North American sales and cautious full-year guidance amid consumer spending pressures. Target (TGT) rose after reporting stronger-than-expected digital sales and improved inventory management ahead of the back-to-school season. 3 Small-Caps on Our Radar for Q3[ad] (By clicking the links above, you will opt you in to receive emails from Stock Wire News newsletter. Unsubscribing is easy. Privacy policy) |